Latest Breaking News On - Neeraj narula - Page 1 : comparemela.com

TRIUMPH: 58% of acute severe UC patients responded within 2 days of starting Xeljanz

WASHINGTON — Nearly 60% of patients with acute severe ulcerative colitis responded to Xeljanz 10 mg twice daily by day 7, with one-third of patients in steroid-free remission by 6 months, according to interim analysis data presented here. “There are few recommended therapies for acute severe UC management given the need for rapidly acting therapies,” Neeraj Narula, MD, MPH,

United statesHeather bieleNeeraj narulaByrobert stottMcmaster universityClinic at hamilton health sciencesHamilton health sciencesModified trueloveWitts severity index

New Study Ties Ultraprocessed Foods to IBD

Researchers identified a higher risk for inflammatory bowel disease among adults who consumed a diet rich in ultraprocessed foods.

British columbiaUnited statesMiguel regueiroBoca ratonNeeraj narulaEric hechtSurgery institute at cleveland clinicInstitute of etiological researchAmerican college of gastroenterologyNurse health studyHealth professionals studyMcmaster universityAmerican collegeEtiological researchInflammatory bowel diseasesHealth professionals follow up study

Delayed Stelara response has similar prognosis to early response in UC, despite severity

Delayed Stelara response has similar prognosis to early response in UC, despite severity
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Neeraj narulaHamilton health sciencesMcmaster university

THE CANADIAN INFLAMMATORY BOWEL DISEASE RESEARCH CONSORTIUM AWARDS FIRST $1M PIONEER GRANT FROM TAKEDA CANADA

/CNW/ - The Canadian Inflammatory Bowel Disease Research Consortium (CIRC) awards the inaugural $1 million PIONEER Grant from Takeda Canada Inc. (Takeda), in.

City ofUnited kingdomAmanda jacobsNeeraj narulaChristopher maSusan elliottRemo panaccioneIleal crohnTalat bessissowCathy luVipul jairathTakeda canada incCumming school of medicineTakeda pharmaceutical company limitedCanadian inflammatory bowel disease research consortiumUniversity of calgary

TNF Blockers Beat Newer Biologics in Crohn s Disease

TNF Blockers Beat Newer Biologics in Crohn s Disease
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNeeraj narulaSimon hongMcmaster universityWestern europeMedscape medicalAmerican journalSimple endoscopic scoreInflammatory bowel disease centerNew york university langone healthNew york cityCrohns diseaseAnti tnfAnti tumor necrosis factorBiologic therapy